Dr. Gerald Post
About Dr. Gerald Post
Dr. Gerald Post is a distinguished veterinary oncologist specializing in precision medicine for canine cancer, with significant contributions to research and clinical practice across a network of over 143 clinics in the US.
Professional Title and Expertise
Dr. Gerald Post, holding the qualifications of DVM, MEM, and DACVIM, serves as the Chief Medical Officer. Specializing in veterinary oncology, Dr. Post is an expert in precision medicine for canine cancer. His role involves working closely with a vast network of over 143 clinics and 180 veterinary oncologists across the United States, enhancing collaboration and the dissemination of knowledge within the field.
Veterinary Oncology Research Contributions
Dr. Gerald Post is significantly involved in research that explores the complex relationship between genetics and disease outcomes in canine cancers. He is part of a team responsible for developing the largest proprietary cancer data set globally. His studies, which have been published in prestigious peer-reviewed journals such as Nature Scientific Reports and Wiley Veterinary and Comparative Oncology, contribute valuable insights into targeted therapies and the genetic markers associated with various canine cancers.
Advancements in Precision Medicine for Canine Cancer
Dr. Gerald Post's contributions to precision medicine for canine cancer are notable. He advocates for the use of targeted therapies tailored to the genetic markers of each dog's specific cancer. This approach has been applied successfully in cases of hemangiosarcoma, bladder cancer, and histiocytic sarcoma, treated using FidoCure®. Dr. Post's efforts support the use of DNA sequencing to identify genetic markers, leading to more effective and personalized treatments for cancer in canines.
Interconnection Between Veterinary and Human Oncology
Dr. Gerald Post believes that insights from veterinary oncology can inform human oncology and vice versa. This interconnection is essential in understanding cancer more comprehensively across species. Dr. Post's work in precision medicine and his advocacy for targeted genetic therapies underscore the potential collaborative benefits between veterinary and human oncology, advancing the fight against cancer through shared knowledge and discoveries.